209 related articles for article (PubMed ID: 29950857)
1. Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.
Zhu X; Zhu R
Onco Targets Ther; 2018; 11():3521-3531. PubMed ID: 29950857
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses the malignant phenotype of laryngeal squamous cell carcinoma through downregulating E2F1 to inhibit FLNA.
Xie Y; Qi J; Liu J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38592439
[TBL] [Abstract][Full Text] [Related]
3. Exosomal lncRNA LINC02191 Promotes Laryngeal Squamous cell Carcinoma Progression by Targeting miR-204-5p/RAB22A Axis and Regulating PI3K/Akt/mTOR Pathway.
Kang Z; Zhang C; Huangfu H
Biochem Genet; 2024 Jun; 62(3):2117-2133. PubMed ID: 37863866
[TBL] [Abstract][Full Text] [Related]
4. The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells.
Yang B; Zang J; Yuan W; Jiang X; Zhang F
Exp Ther Med; 2021 Apr; 21(4):317. PubMed ID: 33717260
[TBL] [Abstract][Full Text] [Related]
5. Silencing of miR-17-5p suppresses cell proliferation and promotes cell apoptosis by directly targeting PIK3R1 in laryngeal squamous cell carcinoma.
Wang JX; Jia XJ; Liu Y; Dong JH; Ren XM; Xu O; Liu SH; Shan CG
Cancer Cell Int; 2020; 20():14. PubMed ID: 31938022
[TBL] [Abstract][Full Text] [Related]
6. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
Wang Z; Huang C; Zhang A; Lu C; Liu L
Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2.
Zhou Y; An H; Wu G
Onco Targets Ther; 2020; 13():9429-9441. PubMed ID: 33061429
[TBL] [Abstract][Full Text] [Related]
9. IncRNA AC004943.2 regulates miR-135a-5p and PTK2/P13K axis to promote laryngeal squamous cell carcinoma progression.
Zhu X; Dong W; Zhang M
J Cell Commun Signal; 2024 Mar; 18(1):e12016. PubMed ID: 38545258
[TBL] [Abstract][Full Text] [Related]
10. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
11. Berberine inhibits the malignant cell phenotype by inactivating PI3K/AKT/mTOR signaling in laryngeal squamous cell carcinoma.
Lin L; Chen Z; Huang P; Chen W; Zou Z; Zheng Y; He C; Gu X; Yu D; Zhang Q
Histol Histopathol; 2024 Apr; ():18753. PubMed ID: 38712806
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
13. MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.
Si F; Sun J; Wang C
Exp Ther Med; 2017 Sep; 14(3):1967-1974. PubMed ID: 28962111
[TBL] [Abstract][Full Text] [Related]
14. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
15. miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1.
Wu X; Cui CL; Chen WL; Fu ZY; Cui XY; Gong X
Am J Transl Res; 2016; 8(1):1-11. PubMed ID: 27069535
[TBL] [Abstract][Full Text] [Related]
16. TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
He G; Pang R; Han J; Jia J; Ding Z; Bi W; Yu J; Chen L; Zhang J; Sun Y
BMC Cancer; 2021 Jun; 21(1):753. PubMed ID: 34187411
[TBL] [Abstract][Full Text] [Related]
17. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
[TBL] [Abstract][Full Text] [Related]
19. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.
Yang N; Hui L; Wang Y; Yang H; Jiang X
Oncol Rep; 2014 Jun; 31(6):2651-9. PubMed ID: 24700142
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of autophagy and PI3K/mTOR pathway as a potential therapeutic strategy against laryngeal squamous cell carcinoma.
Huang HY; Li KN; Lau HC; Hsueh CY; Cong N; Zhang M
Transl Cancer Res; 2022 May; 11(5):1076-1088. PubMed ID: 35706786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
